Detalhe da pesquisa
1.
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens.
Br J Haematol
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710589
2.
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness.
Br J Haematol
; 203(2): 224-236, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37495265
3.
Pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with chronic lymphocytic leukaemia treated with targeted agents.
Br J Haematol
; 201(3): 564-567, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810731
4.
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
Am J Hematol
; 98(9): E237-E240, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382471
5.
Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience.
Front Oncol
; 14: 1370405, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38680863
6.
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course.
Cancers (Basel)
; 16(6)2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539430
7.
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
Front Immunol
; 15: 1393485, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38807597
8.
Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells.
Front Oncol
; 13: 1203470, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293587
9.
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Front Oncol
; 13: 1212752, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37427126
10.
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases.
Curr Oncol
; 29(3): 1455-1460, 2022 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323322
11.
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.
Cancers (Basel)
; 14(6)2022 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326711
12.
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
Curr Oncol
; 30(1): 274-283, 2022 12 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661671
13.
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study.
Front Oncol
; 12: 1033413, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479077